{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:38:55Z","timestamp":1783971535335,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10787-022-00951-x","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T11:03:45Z","timestamp":1648033425000},"page":"883-894","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4777-1841","authenticated-orcid":false,"given":"Nourin","family":"Shakeeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanth","family":"Varkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimy","family":"Hynse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Mandlecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"key":"951_CR1","doi-asserted-by":"publisher","DOI":"10.4172\/2329-6836.1000253","author":"B Am","year":"2017","unstructured":"Am B, Zagorchev P, Filipova MD, Lukanov J (2017) Effects of 1,8-cineole on the activity of cyclooxygenase and cyclooxygenase 1 and cyclooxygenase 2 isoforms. Nat Prod Chem Res. https:\/\/doi.org\/10.4172\/2329-6836.1000253","journal-title":"Nat Prod Chem Res"},{"key":"951_CR2","doi-asserted-by":"publisher","first-page":"9.23.1","DOI":"10.1002\/cpph.19","volume":"76","author":"JK Aronson","year":"2017","unstructured":"Aronson JK, Ferner RE (2017) Biomarkers\u2014a general review. Curr Protoc Pharmacol 76:9.23.1-9.23.17. https:\/\/doi.org\/10.1002\/cpph.19","journal-title":"Curr Protoc Pharmacol"},{"key":"951_CR3","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s10787-020-00744-0","volume":"28","author":"M Asif","year":"2020","unstructured":"Asif M, Saleem M, Saadullah M, Yaseen HS, Al Zarzour R (2020) COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties. Inflammopharmacology 28:1153\u20131161. https:\/\/doi.org\/10.1007\/s10787-020-00744-0","journal-title":"Inflammopharmacology"},{"key":"951_CR5","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","volume":"11","author":"S Bhaskar","year":"2020","unstructured":"Bhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass JS, Rajagopal S, Pai AR, Kutty S (2020) Cytokine storm in COVID-19-immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper. Front Immunol 11:1648. https:\/\/doi.org\/10.3389\/fimmu.2020.01648","journal-title":"Front Immunol"},{"key":"951_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s13054-020-03161-5","volume":"24","author":"X-Y Chen","year":"2020","unstructured":"Chen X-Y, Huang M-Y, Xiao Z, Yang S, Chen X-Q (2020) Lactate dehydrogenase elevations is associated with severity of COVID-19: a meta-analysis. Crit Care 24:459. https:\/\/doi.org\/10.1186\/s13054-020-03161-5","journal-title":"Crit Care"},{"key":"951_CR9","doi-asserted-by":"publisher","first-page":"e06155","DOI":"10.1016\/j.heliyon.2021.e06155","volume":"7","author":"SK Dhar","year":"2021","unstructured":"Dhar SK, Vishnupriyan K, Damodar S, Gujar S, Das M (2021) IL-6 and IL-10 as predictors of disease severity in COVID-19 results from meta-analysis and regression. Heliyon Patients 7:e06155. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06155","journal-title":"Heliyon Patients"},{"key":"951_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1183\/20734735.0329-2019","volume":"15","author":"CC Dobler","year":"2019","unstructured":"Dobler CC (2019) Biomarkers in respiratory diseases. Breathe Sheff Engl 15:265\u2013266. https:\/\/doi.org\/10.1183\/20734735.0329-2019","journal-title":"Breathe Sheff Engl"},{"key":"951_CR11","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200160","volume":"10","author":"A Fara","year":"2020","unstructured":"Fara A, Mitrev Z, Rosalia RA, Assas BM (2020) Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines. Open Biol 10:200160. https:\/\/doi.org\/10.1098\/rsob.200160","journal-title":"Open Biol"},{"key":"951_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, M\u00fcller MA, Drosten C, P\u00f6hlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271-280.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"951_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ffj.3252","volume":"30","author":"G Horv\u00e1th","year":"2015","unstructured":"Horv\u00e1th G, \u00c1cs K (2015) Essential oils in the treatment of respiratory tract diseases highlighting their role in bacterial infections and their anti-inflammatory action: a review. Flavour Fragr J 30:331\u2013341. https:\/\/doi.org\/10.1002\/ffj.3252","journal-title":"Flavour Fragr J"},{"key":"951_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu B, Huang S, Yin L (2021) The cytokine storm and COVID-19. J Med Virol 93:250\u2013256. https:\/\/doi.org\/10.1002\/jmv.26232","journal-title":"J Med Virol"},{"key":"951_CR15","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/jmv.26580","volume":"93","author":"F Huang","year":"2021","unstructured":"Huang F, Liu X, Sun X, Li Z (2021) IL-10 served as an indicator in severe COVID-19 patients. J Med Virol 93:1233\u20131235. https:\/\/doi.org\/10.1002\/jmv.26580","journal-title":"J Med Virol"},{"key":"951_CR16","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.3389\/fimmu.2021.677008","volume":"12","author":"H Islam","year":"2021","unstructured":"Islam H, Chamberlain TC, Mui AL, Little JP (2021) Elevated interleukin-10 levels in COVID-19: potentiation of pro-inflammatory responses or impaired anti-inflammatory action? Front Immunol 12:2485. https:\/\/doi.org\/10.3389\/fimmu.2021.677008","journal-title":"Front Immunol"},{"key":"951_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.synres.2017.08.001","volume":"5","author":"LJ Juergens","year":"2017","unstructured":"Juergens LJ, Rack\u00e9 K, Tuleta I, Stoeber M, Juergens UR (2017) Anti-inflammatory effects of 1,8-cineole (eucalyptol) improve glucocorticoid effects in vitro: a novel approach of steroid-sparing add-on therapy for COPD and asthma? Synergy 5:1\u20138. https:\/\/doi.org\/10.1016\/j.synres.2017.08.001","journal-title":"Synergy"},{"key":"951_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153317","volume":"85","author":"S Kumar","year":"2021","unstructured":"Kumar S, Kashyap P, Chowdhury S, Kumar S, Panwar A, Kumar A (2021) Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication. Phytomedicine 85:153317. https:\/\/doi.org\/10.1016\/j.phymed.2020.153317","journal-title":"Phytomedicine"},{"key":"951_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","volume":"1","author":"R Mayeux","year":"2004","unstructured":"Mayeux R (2004) Biomarkers: potential uses and limitations. NeuroRx 1:182\u2013188","journal-title":"NeuroRx"},{"key":"951_CR23","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","volume":"11","author":"D Ragab","year":"2020","unstructured":"Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R (2020) The COVID-19 cytokine storm; what we know so far. Front Immunol 11:1446. https:\/\/doi.org\/10.3389\/fimmu.2020.01446","journal-title":"Front Immunol"},{"key":"951_CR24","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1111\/jphp.12295","volume":"66","author":"S Ryu","year":"2014","unstructured":"Ryu S, Park H, Seol GH, Choi I-Y (2014) 1,8-Cineole ameliorates oxygen-glucose deprivation\/reoxygenation-induced ischaemic injury by reducing oxidative stress in rat cortical neuron\/glia. J Pharm Pharmacol 66:1818\u20131826. https:\/\/doi.org\/10.1111\/jphp.12295","journal-title":"J Pharm Pharmacol"},{"key":"951_CR25","first-page":"118","volume":"6","author":"A Sengupta","year":"2005","unstructured":"Sengupta A, Ghosh S, Bhattacharjee S (2005) Dietary cardamom inhibits the formation of azoxymethane-induced aberrant crypt foci in mice and reduces COX-2 and iNOS expression in the colon. Asian Pac J Cancer Prev APJCP 6:118\u2013122","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"951_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.plabm.2021.e00226","volume":"25","author":"P Serrano-Lorenzo","year":"2021","unstructured":"Serrano-Lorenzo P, Coya ON, L\u00f3pez-Jimenez A, Bl\u00e1zquez A, Delmiro A, Lucia A, Arenas J, Mart\u00edn MA, Santos-Lozano A, Cueto-Felgueroso C, Pozo AF, de Miguel-Reyes M (2021) Plasma LDH: a specific biomarker for lung affectation in COVID-19? Pract Lab Med 25:e00226. https:\/\/doi.org\/10.1016\/j.plabm.2021.e00226","journal-title":"Pract Lab Med"},{"key":"951_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","volume":"39","author":"HK Siddiqi","year":"2020","unstructured":"Siddiqi HK, Mehra MR (2020) COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant 39:405\u2013407. https:\/\/doi.org\/10.1016\/j.healun.2020.03.012","journal-title":"J Heart Lung Transplant"},{"key":"951_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.11.025","author":"L Szarpak","year":"2020","unstructured":"Szarpak L, Ruetzler K, Safiejko K, Hampel M, Pruc M, Koda, L.K.-, Filipiak, K.J., Jaguszewski, M.J., (2020) Lactate dehydrogenase level as a COVID-19 severity marker. Am J Emerg Med. https:\/\/doi.org\/10.1016\/j.ajem.2020.11.025","journal-title":"Am J Emerg Med"},{"key":"951_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1465-9921-10-69","volume":"10","author":"H Worth","year":"2009","unstructured":"Worth H, Schacher C, Dethlefsen U (2009) Concomitant therapy with cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial. Respir Res 10:69. https:\/\/doi.org\/10.1186\/1465-9921-10-69","journal-title":"Respir Res"},{"key":"951_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108393","volume":"214","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, Wang J, Qin Y, Zhang X, Yan X, Zeng X, Zhang S (2020) The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clin Immunol Orlando Fla 214:108393. https:\/\/doi.org\/10.1016\/j.clim.2020.108393","journal-title":"Clin Immunol Orlando Fla"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-00951-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-00951-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-00951-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T11:23:36Z","timestamp":1653564216000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-00951-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["951"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-00951-x","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,23]]},"assertion":[{"value":"27 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Prashanth is the Director of Zum Heilen Diagnostic & Therapeutics Pvt. Ltd. The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Prior to the study, the protocol was approved by the Orchid Specialty Hospital Ethics committee, and the trial was registered in Clinical Trials Registry India (CTRI\u2014CTRI\/2021\/04\/033143) in compliance with the International Council on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use\u2014Good Clinical Practice (ICH\u2013GCP) guidelines. All participating patients were informed about the objectives and risks of participation and gave written informed consent. This study was approved by the Orchid Specialty Hospital Ethics committee, and the trial was registered in Clinical Trials Registry India (CTRI\u2014CTRI\/2021\/04\/033143) in compliance with the International Council on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use\u2013Good Clinical Practice (ICH\u2013GCP) guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate (human ethics, animal ethics or plant ethics)"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors mentioned in the manuscript have agreed for authorship, read and approved the manuscript, and have given consent for submission and subsequent publication of the manuscript. No images or videos of patients included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}